A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Witnesses reported hearing a "huge bang" at the venue during the concert on Monday evening.
ITV News travels to Britain's eastern-most city to gauge how the electorate will be casting its votes.
Carefully choreographed campaigns can become unstuck because voters have the power to peel back a politician's veneer.